Slides [PDF, 378.59 Kb] - Tessenderlo Group

REBITDA (% of total)2.5%44.1mEUR125 110.61007550250Other Businesses** Includes Compounds, OCD, Pharma, Water Treatment and Sulphur DerivativesRevenue (Million EUR)(19.4)91.61Q111Q12Scope9876543210REBITDA (Million EUR) &REBITDA margin (%)6.4%7.0(0.8)1Q111.31Q121.4%6%5%4%3%2%1%0%-1%Revenue1Q12REBITDA1Q12% Change atcomparable scope+0.3%% Change atcomparable scope-78.9%• 1Q12 segment revenue was virtually unchanged at +0.3%; Compounds grew further driven byautomotive sector demand; OCD, Water Treatment and Pharma also rose, while Sulfur Derivativeswas lower• Segment REBITDA in 1Q12 fell 78.9% compared to the very high 1Q11 figure; Compounds improvedwhile OCD and Pharma had much lower margins in 1Q1213Financial data from continuing operations